• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群失调明显,亚氨二丙酸增加与 NASH 哥廷根猪模型有关。

Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.

机构信息

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1871, Frederiksberg C, Denmark.

School of Science and Technology, Örebro University, 702 81, Örebro, Sweden.

出版信息

BMC Microbiol. 2022 Dec 1;22(1):287. doi: 10.1186/s12866-022-02704-w.

DOI:10.1186/s12866-022-02704-w
PMID:36456963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9717514/
Abstract

BACKGROUND

Gut microbiota dysbiosis is associated with the development of non-alcoholic steatohepatitis (NASH) through modulation of gut barrier, inflammation, lipid metabolism, bile acid signaling and short-chain fatty acid production. The aim of this study was to describe the impact of a choline-deficient amino acid defined high fat diet (CDAHFD) on the gut microbiota in a male Göttingen Minipig model and on selected pathways implicated in the development of NASH.

RESULTS

Eight weeks of CDAHFD resulted in a significantly altered colon microbiota mainly driven by the bacterial families Lachnospiraceae and Enterobacteriaceae, being decreased and increased in relative abundance, respectively. Metabolomics analysis revealed that CDAHFD decreased colon content of short-chain fatty acid and increased colonic pH. In addition, serum levels of the microbially produced metabolite imidazole propionate were significantly elevated as a consequence of CDAHFD feeding. Hepatic gene expression analysis showed upregulation of mechanistic target of rapamycin (mTOR) and Ras Homolog, MTORC1 binding in addition to downregulation of insulin receptor substrate 1, insulin receptor substrate 2 and the glucagon receptor in CDAHFD fed minipigs. Further, the consequences of CDAHFD feeding were associated with increased levels of circulating cholesterol, bile acids, and glucagon but not total amino acids.

CONCLUSIONS

Our results indicate imidazole propionate as a new potentially relevant factor in relation to NASH and discuss the possible implication of gut microbiota dysbiosis in the development of NASH. In addition, the study emphasizes the need for considering the gut microbiota and its products when developing translational animal models for NASH.

摘要

背景

肠道微生物失调通过调节肠道屏障、炎症、脂质代谢、胆汁酸信号和短链脂肪酸生成,与非酒精性脂肪性肝炎(NASH)的发展有关。本研究旨在描述胆碱缺乏氨基酸定义的高脂肪饮食(CDAHFD)对雄性哥廷根小型猪模型肠道微生物群的影响,以及对 NASH 发生中涉及的选定途径的影响。

结果

CDAHFD 喂养 8 周导致结肠微生物群发生显著改变,主要由细菌家族 Lachnospiraceae 和肠杆菌科驱动,相对丰度分别降低和增加。代谢组学分析显示,CDAHFD 降低了结肠中短链脂肪酸的含量,增加了结肠 pH 值。此外,由于 CDAHFD 喂养,血清中微生物产生的代谢物咪唑丙酸的水平显著升高。肝基因表达分析显示,CDAHFD 喂养的小型猪中,机械性靶标雷帕霉素(mTOR)和 Ras Homolog、MTORC1 结合的 Ras Homolog 上调,胰岛素受体底物 1、胰岛素受体底物 2 和胰高血糖素受体下调。此外,CDAHFD 喂养的后果与循环胆固醇、胆汁酸和胰高血糖素水平升高有关,但与总氨基酸水平无关。

结论

我们的研究结果表明,咪唑丙酸是与 NASH 相关的一个新的潜在相关因素,并讨论了肠道微生物失调在 NASH 发展中的可能影响。此外,该研究强调在开发 NASH 的转化动物模型时,需要考虑肠道微生物群及其产物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/716b847f203a/12866_2022_2704_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/f6cb6c318c11/12866_2022_2704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/957ffaf9c3a8/12866_2022_2704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/bc1241266292/12866_2022_2704_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/802b3dcd22de/12866_2022_2704_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/716b847f203a/12866_2022_2704_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/f6cb6c318c11/12866_2022_2704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/957ffaf9c3a8/12866_2022_2704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/bc1241266292/12866_2022_2704_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/802b3dcd22de/12866_2022_2704_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f12/9717514/716b847f203a/12866_2022_2704_Fig5_HTML.jpg

相似文献

1
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.肠道微生物群失调明显,亚氨二丙酸增加与 NASH 哥廷根猪模型有关。
BMC Microbiol. 2022 Dec 1;22(1):287. doi: 10.1186/s12866-022-02704-w.
2
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.FXR-FGF19 信号失调和胆碱代谢与儿科 NASH 新型猪模型中的肠道菌群失调和增生有关。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G582-G609. doi: 10.1152/ajpgi.00344.2019. Epub 2020 Jan 31.
3
High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Göttingen Minipigs.高脂肪饮食与肠道微生物群落失调以及与年轻哥廷根小型猪代谢健康相关的肠道微生物衍生代谢物减少有关。
PLoS One. 2024 Mar 1;19(3):e0298602. doi: 10.1371/journal.pone.0298602. eCollection 2024.
4
Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.胆碱缺乏、高脂肪饮食诱导的哥廷根小型猪 MASH:特征描述及膳食逆转期的影响。
Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G571-G585. doi: 10.1152/ajpgi.00120.2024. Epub 2024 Jul 23.
5
NASH-inducing Diets in Göttingen Minipigs.诱导哥廷根小型猪发生非酒精性脂肪性肝炎的饮食
J Clin Exp Hepatol. 2020 May-Jun;10(3):211-221. doi: 10.1016/j.jceh.2019.09.004. Epub 2019 Sep 21.
6
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.肠道微生物群驱动的肠道血管屏障破坏是非酒精性脂肪性肝炎发展的前提。
J Hepatol. 2019 Dec;71(6):1216-1228. doi: 10.1016/j.jhep.2019.08.005. Epub 2019 Aug 13.
7
Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH).胆碱缺乏型 L-氨基酸定义的高脂肪饮食(CDAHFD)诱导的非酒精性脂肪性肝炎(NASH)小鼠模型中血清胆固醇和甘油三酯水平降低。
Biol Pharm Bull. 2020;43(4):616-618. doi: 10.1248/bpb.b19-00338.
8
Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.基于自组装聚合物的短链脂肪酸前药可改善非酒精性脂肪性肝炎和肝纤维化。
Biomaterials. 2023 Apr;295:122047. doi: 10.1016/j.biomaterials.2023.122047. Epub 2023 Feb 17.
9
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.肠道微生物群对非酒精性脂肪性肝炎发生发展的影响。
Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5.
10
Gubra Amylin-NASH Diet Induced Nonalcoholic Fatty Liver Disease Associated with Histological Damage, Oxidative Stress, Immune Disorders, Gut Microbiota, and Its Metabolic Dysbiosis in Colon.Gubra 胰淀素-NASH 饮食诱导的非酒精性脂肪性肝病与组织学损伤、氧化应激、免疫紊乱、肠道微生物群及其在结肠中的代谢失调有关。
Mol Nutr Food Res. 2024 Aug;68(15):e2300845. doi: 10.1002/mnfr.202300845. Epub 2024 Jul 5.

引用本文的文献

1
Diet, Gut Microbiota, and Histidine Metabolism Toward Imidazole Propionate Production in Relation to Type 2 Diabetes.饮食、肠道微生物群与组氨酸代谢生成咪唑丙酸的关系及其与2型糖尿病的关联
Diabetes Care. 2025 Jul 1;48(7):1225-1232. doi: 10.2337/dc24-2816.
2
Gut microbiota-derived imidazole propionate: an emerging target for the prevention and treatment of cardiometabolic diseases.肠道微生物群衍生的咪唑丙酸:预防和治疗心脏代谢疾病的新兴靶点。
Front Endocrinol (Lausanne). 2025 Feb 17;16:1409119. doi: 10.3389/fendo.2025.1409119. eCollection 2025.
3
Isolation, Structure, and Biological Activities of Exopolysaccharides from Actinomycetes: A Review.

本文引用的文献

1
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology.丙酸咪唑在糖尿病中增加,并与饮食模式和微生物生态的改变有关。
Nat Commun. 2020 Nov 18;11(1):5881. doi: 10.1038/s41467-020-19589-w.
2
Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis.非酒精性脂肪性肝病损害肝脏-胰岛α细胞轴,且独立于肝脏炎症和纤维化。
Hepatol Commun. 2020 Sep 1;4(11):1610-1623. doi: 10.1002/hep4.1562. eCollection 2020 Nov.
3
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD.
放线菌胞外多糖的分离、结构与生物活性:综述
Curr Microbiol. 2024 Dec 18;82(1):45. doi: 10.1007/s00284-024-03999-w.
4
Anticipatory in silico vaccine designing based on specific antigenic epitopes from against diabetic pathogenesis.基于针对糖尿病发病机制的特定抗原表位进行的计算机辅助疫苗设计。
In Silico Pharmacol. 2024 Sep 18;12(2):86. doi: 10.1007/s40203-024-00260-x. eCollection 2024.
5
Imidazole propionate in type 2 diabetes mellitus and cardiovascular diseases: a mini review.咪唑丙酸在 2 型糖尿病和心血管疾病中的作用:小型综述。
Front Immunol. 2024 Aug 29;15:1454210. doi: 10.3389/fimmu.2024.1454210. eCollection 2024.
6
The Relationship Between Gut Microbiome Estrobolome and Breast Cancer: A Systematic Review of Current Evidences.肠道微生物群雌激素代谢组与乳腺癌的关系:当前证据的系统评价
Indian J Microbiol. 2024 Mar;64(1):1-19. doi: 10.1007/s12088-023-01135-z. Epub 2023 Nov 23.
7
High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Göttingen Minipigs.高脂肪饮食与肠道微生物群落失调以及与年轻哥廷根小型猪代谢健康相关的肠道微生物衍生代谢物减少有关。
PLoS One. 2024 Mar 1;19(3):e0298602. doi: 10.1371/journal.pone.0298602. eCollection 2024.
8
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease.益生菌对非酒精性脂肪性肝病患者小肠微生物群组成、炎性细胞因子及肠道通透性的影响
Biomedicines. 2023 Feb 20;11(2):640. doi: 10.3390/biomedicines11020640.
非肥胖型非酒精性脂肪性肝病患者中与显著肝纤维化相关的肠道微生物组和代谢物的独特特征。
Nat Commun. 2020 Oct 5;11(1):4982. doi: 10.1038/s41467-020-18754-5.
4
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH.肠-胰-肝轴作为治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎的靶点。
Int J Mol Sci. 2020 Aug 13;21(16):5820. doi: 10.3390/ijms21165820.
5
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation.微生物咪唑丙酸通过 p38γ 依赖性抑制 AMPK 磷酸化影响二甲双胍的反应。
Cell Metab. 2020 Oct 6;32(4):643-653.e4. doi: 10.1016/j.cmet.2020.07.012. Epub 2020 Aug 11.
6
NASH-inducing Diets in Göttingen Minipigs.诱导哥廷根小型猪发生非酒精性脂肪性肝炎的饮食
J Clin Exp Hepatol. 2020 May-Jun;10(3):211-221. doi: 10.1016/j.jceh.2019.09.004. Epub 2019 Sep 21.
7
Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.人 2 型糖尿病中胰岛α细胞胰高血糖素分泌的旁分泌调控受损。
Nat Commun. 2020 Apr 20;11(1):1896. doi: 10.1038/s41467-020-15717-8.
8
SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD.短链脂肪酸可缓解 MCD 诱导的 NASH 小鼠的脂肪变性和炎症。
J Endocrinol. 2020 Jun;245(3):425-437. doi: 10.1530/JOE-20-0018.
9
Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis.胰高血糖素通过 INSP3R1 介导的肝脂解刺激糖异生。
Nature. 2020 Mar;579(7798):279-283. doi: 10.1038/s41586-020-2074-6. Epub 2020 Mar 4.
10
Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease.胆汁酸在肠道菌群失调及非酒精性脂肪性肝病治疗中的作用
Mediators Inflamm. 2019 Jun 24;2019:7659509. doi: 10.1155/2019/7659509. eCollection 2019.